期刊文献+

红花注射液对脓毒性休克患者病情评估及临床预后影响的研究 被引量:1

Study on the effects of safflower injection on the condition evaluation and clinical prognosis in the septic shock patients
下载PDF
导出
摘要 目的通过完全随机对照设计方案,观察红花注射液对脓毒性休克患者病情评估及临床预后的影响,研究其治疗脓毒性休克的有效性。方法脓毒性休克患者,随机分为两组,在常规使用早期目标导向治疗(EGDT)的基础上,研究组使用红花注射液抗休克,记录各组APACHEⅡ评分,比较组间差异,抗休克治疗前后差异,比较红花注射液对脓毒性休克患者病情评估及临床预后的影响。结果两组患者抗休克治疗前后总体比较、死亡亚组比较、对照组存活亚组比较,APACHEⅡ评分无统计学差异(P>0.05),两组患者28d病死率无统计学意义(P>0.05),研究组存活亚组使用红花注射液抗休克治疗前后比较,APACHEⅡ评分有统计学差异(P<0.05)。结论红花注射液在促进脓毒性休克患者APACHEⅡ评分降低,改善病情,提高生存率方面有一定临床意义。 Objective To observe the effects of safflower injection on the condition evaluation and clinical prognosis in the septic shock patients through completely randomized design. Method Septic shock patients, randomly divided into two groups on the basis of routine use the early goal-directed therapy (EGDT). The study group used safflower injection against shock. Recording APACHE II scores of the two groups, the differences between the two groups and the differences before and after treat- ment of shock were compared. Results APACHE I1 scores had no significance before and after treatment in the two group. There was no significance of 28 days mortality between the two groups (P 〉 0. 05) , While there was significance in APACHE II scores before and after treatment in survival subgroup of the study group (P 〈 0. 05 ). Conclusion Safflower injection should de- crease APACHE II scores in patients with septic shock, and improve the condition of patients and the survival rate.
出处 《四川医学》 CAS 2013年第12期1777-1779,共3页 Sichuan Medical Journal
基金 四川省科学技术厅2011年重点科技项目课题(编号:川科计﹝2011SZZ001﹞)
关键词 红花注射液 脓毒性休克 APACHEⅡ评分 生存率 Safflower injection septic shock APACHE II score rate of survivors
  • 相关文献

参考文献7

二级参考文献86

共引文献133

同被引文献19

  • 1李国福,汪海源,吴兴茂,张首梅,吉凯强,臧彬.早期目标指导治疗对脓毒性休克患者全身氧代谢与胃黏膜酸度的影响[J].中国医科大学学报,2009,38(4):296-298. 被引量:1
  • 2Dellinger R P,Levy M M,Rhodes A,et al.Surviving Sepsis Campaign:international guidelines for management of severe sepsis and septic shock:2012[J].Crit Care Med,2013,41(2):580-637.
  • 3Dellinger R P,Levy M M,Carlet J M,et al.Surviving Sepsis Campaign:international guidelines for management of severe sepsis and septic shock:2008[J].Crit Care Med,2008,36(1):296-327.
  • 4Dellinger R P,Carlet J M,Masur H,et al.Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock[J].Crit Care Med,2004,32:858-73.
  • 5Jawad I,Luksic I,Rafnsson S B.Assessing available information on the burden of sepsis:global estimates of incidence,prevalence and mortality[J].J Glob Health,2012,2(1):010404.
  • 6Torio C M,Andrews R M.Healthcare Cost and Utilization Project(HCUP)statistical briefs-national inpatient hospital costs:the most expensive conditions by payer,2011.Statistical brief#160[M].Rockville,MD:Agency for Health Care Policy and Research,2013.
  • 7Cuthbertson B H,Elders A,Hall S,et al.Mortality and quality of life in the five years after severe sepsis[J].Crit Care,2013,17(2):R70-R70.
  • 8Kaukonen K M,Bailey M,Suzuki S,et al.Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand,2000-2012[J].JAMA,2014,311(13):1308-1316.
  • 9Levy M M,Artigas A,Phillips G S,et al.Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe:aprospective cohort study[J].Lancet Infect Dis,2012,12(12):919-924.
  • 10吴健锋,陈娟,欧阳彬,杨春华,陈敏英,黄顺伟,管向东.集束化治疗依从性及对严重脓毒症和脓毒性休克病人病死率影响的研究[J].中国实用外科杂志,2009,29(12):1006-1008. 被引量:5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部